Inhaled insulin forms toxic pulmonary amyloid aggregates

Cristian A. Lasagna-Reeves, Audra L. Clos, Terumi Midoro-Horiuti, Randall M. Goldblum, George R. Jackson, Rakez Kayed

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

It is well known that interfaces, such as polar-nonpolar or liquid-air, play a key role in triggering protein aggregation in vitro, in particular the aggregation of peptides and proteins with the predisposition of misfolding and aggregation. Here we show that the interface present in the lungs predisposes the lungs to form aggregation of inhaled insulin. Insulin inhalers were introduced, and a large number of diabetic patients have used them. Although inhalers were safe and effective, decreases in pulmonary capacity have been reported in response to inhaled insulin. We hypothesize that the lung air-tissue interface provides a template for the aggregation of inhaled insulin. Our studies were designed to investigate the harmful potential that inhaled insulin has in pulmonary tissue in vivo, through an amyloid formation mechanism. Our data demonstrate that inhaled insulin rapidly forms amyloid in the lungs causing a significant reduction in pulmonary air flow. Our studies exemplify the importance that interfaces play in protein aggregation in vivo, illustrating the potential aggregation of inhaled proteins and the formation of amyloid deposits in the lungs. These insulin deposits resemble the amyloid structures implicated in protein misfolding disorders, such as Alzheimer's and Parkinson's diseases, and could as well be deleterious in nature.

Original languageEnglish (US)
Pages (from-to)4717-4724
Number of pages8
JournalEndocrinology
Volume151
Issue number10
DOIs
StatePublished - 2010

Fingerprint

Poisons
Amyloid
Insulin
Lung
Nebulizers and Vaporizers
Air
Amyloid Plaques
Proteins
Proteostasis Deficiencies
Lung Volume Measurements
Parkinson Disease
Alzheimer Disease
Peptides

ASJC Scopus subject areas

  • Endocrinology
  • Medicine(all)

Cite this

Lasagna-Reeves, C. A., Clos, A. L., Midoro-Horiuti, T., Goldblum, R. M., Jackson, G. R., & Kayed, R. (2010). Inhaled insulin forms toxic pulmonary amyloid aggregates. Endocrinology, 151(10), 4717-4724. https://doi.org/10.1210/en.2010-0457

Inhaled insulin forms toxic pulmonary amyloid aggregates. / Lasagna-Reeves, Cristian A.; Clos, Audra L.; Midoro-Horiuti, Terumi; Goldblum, Randall M.; Jackson, George R.; Kayed, Rakez.

In: Endocrinology, Vol. 151, No. 10, 2010, p. 4717-4724.

Research output: Contribution to journalArticle

Lasagna-Reeves, CA, Clos, AL, Midoro-Horiuti, T, Goldblum, RM, Jackson, GR & Kayed, R 2010, 'Inhaled insulin forms toxic pulmonary amyloid aggregates', Endocrinology, vol. 151, no. 10, pp. 4717-4724. https://doi.org/10.1210/en.2010-0457
Lasagna-Reeves, Cristian A. ; Clos, Audra L. ; Midoro-Horiuti, Terumi ; Goldblum, Randall M. ; Jackson, George R. ; Kayed, Rakez. / Inhaled insulin forms toxic pulmonary amyloid aggregates. In: Endocrinology. 2010 ; Vol. 151, No. 10. pp. 4717-4724.
@article{d0cf7d345147402aba159540bddcb125,
title = "Inhaled insulin forms toxic pulmonary amyloid aggregates",
abstract = "It is well known that interfaces, such as polar-nonpolar or liquid-air, play a key role in triggering protein aggregation in vitro, in particular the aggregation of peptides and proteins with the predisposition of misfolding and aggregation. Here we show that the interface present in the lungs predisposes the lungs to form aggregation of inhaled insulin. Insulin inhalers were introduced, and a large number of diabetic patients have used them. Although inhalers were safe and effective, decreases in pulmonary capacity have been reported in response to inhaled insulin. We hypothesize that the lung air-tissue interface provides a template for the aggregation of inhaled insulin. Our studies were designed to investigate the harmful potential that inhaled insulin has in pulmonary tissue in vivo, through an amyloid formation mechanism. Our data demonstrate that inhaled insulin rapidly forms amyloid in the lungs causing a significant reduction in pulmonary air flow. Our studies exemplify the importance that interfaces play in protein aggregation in vivo, illustrating the potential aggregation of inhaled proteins and the formation of amyloid deposits in the lungs. These insulin deposits resemble the amyloid structures implicated in protein misfolding disorders, such as Alzheimer's and Parkinson's diseases, and could as well be deleterious in nature.",
author = "Lasagna-Reeves, {Cristian A.} and Clos, {Audra L.} and Terumi Midoro-Horiuti and Goldblum, {Randall M.} and Jackson, {George R.} and Rakez Kayed",
year = "2010",
doi = "10.1210/en.2010-0457",
language = "English (US)",
volume = "151",
pages = "4717--4724",
journal = "Endocrinology",
issn = "0013-7227",
publisher = "The Endocrine Society",
number = "10",

}

TY - JOUR

T1 - Inhaled insulin forms toxic pulmonary amyloid aggregates

AU - Lasagna-Reeves, Cristian A.

AU - Clos, Audra L.

AU - Midoro-Horiuti, Terumi

AU - Goldblum, Randall M.

AU - Jackson, George R.

AU - Kayed, Rakez

PY - 2010

Y1 - 2010

N2 - It is well known that interfaces, such as polar-nonpolar or liquid-air, play a key role in triggering protein aggregation in vitro, in particular the aggregation of peptides and proteins with the predisposition of misfolding and aggregation. Here we show that the interface present in the lungs predisposes the lungs to form aggregation of inhaled insulin. Insulin inhalers were introduced, and a large number of diabetic patients have used them. Although inhalers were safe and effective, decreases in pulmonary capacity have been reported in response to inhaled insulin. We hypothesize that the lung air-tissue interface provides a template for the aggregation of inhaled insulin. Our studies were designed to investigate the harmful potential that inhaled insulin has in pulmonary tissue in vivo, through an amyloid formation mechanism. Our data demonstrate that inhaled insulin rapidly forms amyloid in the lungs causing a significant reduction in pulmonary air flow. Our studies exemplify the importance that interfaces play in protein aggregation in vivo, illustrating the potential aggregation of inhaled proteins and the formation of amyloid deposits in the lungs. These insulin deposits resemble the amyloid structures implicated in protein misfolding disorders, such as Alzheimer's and Parkinson's diseases, and could as well be deleterious in nature.

AB - It is well known that interfaces, such as polar-nonpolar or liquid-air, play a key role in triggering protein aggregation in vitro, in particular the aggregation of peptides and proteins with the predisposition of misfolding and aggregation. Here we show that the interface present in the lungs predisposes the lungs to form aggregation of inhaled insulin. Insulin inhalers were introduced, and a large number of diabetic patients have used them. Although inhalers were safe and effective, decreases in pulmonary capacity have been reported in response to inhaled insulin. We hypothesize that the lung air-tissue interface provides a template for the aggregation of inhaled insulin. Our studies were designed to investigate the harmful potential that inhaled insulin has in pulmonary tissue in vivo, through an amyloid formation mechanism. Our data demonstrate that inhaled insulin rapidly forms amyloid in the lungs causing a significant reduction in pulmonary air flow. Our studies exemplify the importance that interfaces play in protein aggregation in vivo, illustrating the potential aggregation of inhaled proteins and the formation of amyloid deposits in the lungs. These insulin deposits resemble the amyloid structures implicated in protein misfolding disorders, such as Alzheimer's and Parkinson's diseases, and could as well be deleterious in nature.

UR - http://www.scopus.com/inward/record.url?scp=77957288054&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957288054&partnerID=8YFLogxK

U2 - 10.1210/en.2010-0457

DO - 10.1210/en.2010-0457

M3 - Article

VL - 151

SP - 4717

EP - 4724

JO - Endocrinology

JF - Endocrinology

SN - 0013-7227

IS - 10

ER -